Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer

$Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer$

Journal article

Peer reviewed

C. L VOGEL, I SHEMANO, J SCHOENFELDER, R. A GAMS and M. R GREEN

Journal of clinical oncology, Vol.11(2), pp.345-350

1993

PMID: 8426212

Abstract

Biological and medical sciences

Chemotherapy

Medical sciences

Antineoplastic agents

Pharmacology. Drug treatments

12 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.141 Hormone Therapy; 1.141.244 Tamoxifen
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer
Creators: C. L VOGEL - Comprehensive Cancer Research Group Inc., Miami FL, United States
I SHEMANO - Comprehensive Cancer Research Group Inc., Miami FL, United States
J SCHOENFELDER - Comprehensive Cancer Research Group Inc., Miami FL, United States
R. A GAMS - Comprehensive Cancer Research Group Inc., Miami FL, United States
M. R GREEN - Comprehensive Cancer Research Group Inc., Miami FL, United States
Publication Details: Journal of clinical oncology, Vol.11(2), pp.345-350
Publisher: Lippincott Williams & Wilkins; Baltimore, MD
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 8426212
Record Identifier: 991031559505002976